Referral information
Understand who may be eligible for the WATCHMAN Implant.
Identify which of your Afib patients may benefit from the WATCHMAN Implant
The WATCHMAN Implant may be suitable for a broad range of non-valvular Afib (NVAF) patients and may be an appropriate option for your NVAF patients who meet these criteria. Eligible patients must:
- Have an increased risk for stroke and be recommended for anticoagulation (OAC)
- Be suitable for short-term oral anticoagulation*
- Have an appropriate reason to seek a non-pharmacologic alternative to OACs
*Option for immediate DAPT-only post-implant drug regimen
Designed to treat a broad range of patient types
Past bleed
A major or minor bleeding episode
Increased risk of future bleed
- Due to work or activities that increase risk of falling or bleeding
- Caused by other medications that increase bleeding risk
- Caused by side effects of oral anticoagulation (OACs), such as bleeding risk based on HAS-BLED score or other factors
Increased risk of stroke
History of stroke due to:
- Non-compliance
- Inability to maintain INR
Hear how WATCHMAN has positively impacted patients' quality of life
Patient Perspective
Getting a WATCHMAN Implant has made a huge difference in Wayne’s life. Being very active, he immediately knew that the risks and side effects of blood thinners would hold him back from the life he wanted to live. After his implant procedure, he’s back to yoga, hiking and volunteering — all without the worries of bleeding or stroke.
Cardiologist Perspective
Cardiologists describe the impact WATCHMAN has had on their patients. Hear how after receiving the WATCHMAN Implant, patients were able to go back to their everyday activities without the worry of OAC bleed risk. Hear more about the different patient types who were candidates for the WATCHMAN Implant.
Determine if your Afib patient is a good candidate for WATCHMAN
Review the patient screening and referral form to help identify potential WATCHMAN candidates.
* DAPT-only post-implant drug regimen now available